Purpose:This investigation explored factors associated with premenstrual syndrome(PMS)in minority women,and compared the response of minority and non-minority women supplemented with omega-3 fatty acids(FA)in the form...Purpose:This investigation explored factors associated with premenstrual syndrome(PMS)in minority women,and compared the response of minority and non-minority women supplemented with omega-3 fatty acids(FA)in the form of fish oil.Methods:This descriptive,correlational,retrospective pilot was a secondary data analysis.Participants consuming 2 g of fish oil/d(n=15)in the larger study were included.The Moos Menstrual Distress Questionnaire(MMDQ)was assessed monthly for two months to acquire a mean baseline MMDQ score.The total sample was stratified to evaluate racial variations in PMS symptoms(non-minority,n=7;minority,n=8).MMDQ score at 5 months was compared to the mean baseline score within each group.Results:Fish oil supplementation significantly reduced PMS symptoms in both groups(nonminority p=0.002;minority p=0.046)with a large effect of 1.4 for both groups.Mean MMDQ total scores were not significantly different between groups at 5 months.Conclusions:This pilot evidence of improved PMS symptoms in minority and non-minority groups related to fish oil supplementation supports a universal treatment approach and highlights need for a larger-scale investigation.展开更多
基金This research was supported by the University of Connecticut Rowe Scholars Program,Summer Undergraduate Research Fundthe Mr.Michael Alpert and Ariana Napier Honors Enrichment Scholarship.
文摘Purpose:This investigation explored factors associated with premenstrual syndrome(PMS)in minority women,and compared the response of minority and non-minority women supplemented with omega-3 fatty acids(FA)in the form of fish oil.Methods:This descriptive,correlational,retrospective pilot was a secondary data analysis.Participants consuming 2 g of fish oil/d(n=15)in the larger study were included.The Moos Menstrual Distress Questionnaire(MMDQ)was assessed monthly for two months to acquire a mean baseline MMDQ score.The total sample was stratified to evaluate racial variations in PMS symptoms(non-minority,n=7;minority,n=8).MMDQ score at 5 months was compared to the mean baseline score within each group.Results:Fish oil supplementation significantly reduced PMS symptoms in both groups(nonminority p=0.002;minority p=0.046)with a large effect of 1.4 for both groups.Mean MMDQ total scores were not significantly different between groups at 5 months.Conclusions:This pilot evidence of improved PMS symptoms in minority and non-minority groups related to fish oil supplementation supports a universal treatment approach and highlights need for a larger-scale investigation.
